Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Drug Development, NCI CTEP

Richard Schilsky

MD

🏢University of Chicago🌐USA

Professor Emeritus of Medicine

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Richard Schilsky is a veteran cancer drug developer and clinical trials leader who served as Chief Medical Officer of ASCO for a decade. His career-long contributions to clinical trial design methodology, cooperative group oncology research, and cancer drug development policy have shaped the infrastructure of cancer clinical research. He was also involved in TCGA and precision medicine initiatives advancing genomically-guided cancer trials.

Share:

🧪Research Fields 研究领域

cancer drug development
NCI CTEP
cooperative group trials
ASCO leadership
cancer clinical trials infrastructure

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Richard Schilsky 的研究动态

Follow Richard Schilsky's research updates

留下邮箱,当我们发布与 Richard Schilsky(University of Chicago)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment